BIOS NASDAQ
BioPlus Acquisition Corp.
1W: +0.0%
1M: +0.2%
3M: +1.3%
1Y: +7.5%
$10.79
Last traded 2023-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
+0.0% ▲
Operating Income
-$1M
-720821.5% ▼
Net Income
$5M
+3375823.3% ▲
EPS (Diluted)
$0.20
+1000.9% ▲
EBITDA
-$1M
-12344607.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $936M | $817M | $709M | $0 | $0 |
| YoY Growth | -4.7% | -12.7% | -13.3% | +0.0% | +0.0% |
| Cost of Revenue | $670M | $548M | $466M | $0 | $1M |
| Gross Profit | $266M | $269M | $243M | $0 | -$1M |
| Gross Margin | 28.4% | 33.0% | 34.3% | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $66M | $63M | $47M | $162 | $1K |
| Operating Expenses | $264M | $284M | $237M | $162 | $1K |
| Operating Income | -$78M | -$53M | -$108M | -$162 | -$1M |
| Operating Margin | -8.3% | -6.4% | -15.3% | — | — |
| Interest Expense | -$38M | -$52M | -$57M | $0 | $0 |
| Income Before Tax | -$32M | -$67M | -$51M | -$153 | $2M |
| Tax Expense | $2M | $64M | $600K | $0 | -$3M |
| Net Income | -$34M | -$131M | -$52M | -$153 | $5M |
| Net Margin | -3.7% | -16.0% | -7.3% | — | — |
| EPS (Diluted) | $-0.37 | $-1.06 | $-0.40 | $-0.02 | $0.20 |
| EBITDA | -$56M | -$25M | -$85M | $9 | -$1M |
| Shares Outstanding | 94M | 124M | 128M | 6876 | 26M |